Abstract
Efficacy and safety of USL255 (Qudexy™ XR; extended-release topiramate) for adjunctive treatment of partial-onset seizures: The PREVAIL study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have